Healthcare Industry News: z.one ultrasound system
News Release - November 27, 2006
ZONARE Announces Another Milestone at Radiology Society of North AmericaFastest Growing Ultrasound Company Reaches 500 Worldwide Convertible Ultrasound(TM) Platform Installations
CHICAGO, Nov. 27 (HSMN NewsFeed) -- ZONARE Medical Systems, a developer of next generation ultrasound technology, announced at the annual Radiology Society of North America (RSNA) meeting being held November 25 - December 1, 2006 that the company has reached 500 worldwide installations of its z.one ultrasound system, marking another milestone for ZONARE. Based on revolutionary Zone Sonography(TM) technology, the z.one system is the world's first and only Convertible Ultrasound(TM) platform. Sales of the system have been doubling approximately every six months since shipments began in Spring of 2005.
"It's very understandable why ZONARE is the fastest growing ultrasound company in the market today," said Michael Racenstein, MD, attending radiologist for Rush North Shore and past president of the Chicago Radiology Society. "This revolutionary technology provides an incredible price to value ratio. We are extremely impressed with the z.one system due to its convertibility from a full-cart to a compact, portable system without image compromise. In fact, we traded in a one-year old system from another manufacturer because the z.one fulfilled our needs far better."
Zone Sonography technology has allowed ZONARE Medical Systems to bring the first Convertible Ultrasound platform to the industry with superb image quality at a substantial price to value ratio. Clinicians are able to instantly convert the z.one platform from a full-featured, cart-based system into a premium compact, ultrasound system with all the performance of substantially larger and more expensive ultrasound units, yet, with greater portability and clinical flexibility than conventional compact systems.
The z.one platform's Zone Sonography software-based architecture ensures that its performance will increase as improvements in processing power become available. This allows for fast, convenient upgrades in clinical capabilities, keeping clinicians at the forefront of diagnostic capabilities as well as protecting their investment. Software upgrades can be downloaded via the internet, another industry first.
"As the power of Zone Sonography technology propels significant advances in the performance of the z.one system, acceptance of ZONARE's Convertible Ultrasound platform are growing exponentially," said Donald Southard, president and CEO of ZONARE. "We believe this highly scaleable technology brings an exceptional value to the clinician, both economically and clinically. We look forward to the ongoing growth of worldwide z.one system installations."
ZONARE field personnel have doubled during the past year and are located throughout North America, Europe and Asia. In addition, there are more than 25 distributors located in Latin America, Asia, North America, UK, Europe, Middle East and the Mediterranean.
According to The Medical Diagnostic Ultrasound Market in the USA published in April of 2006, which covers annual industry trends, ZONARE's z.one system is the beginning of a new wave of convertible systems. The report is published annually by the ultrasound industry's leading analyst, Harvey Klein of Klein Biomedical Consultants.
About ZONARE Medical Systems
ZONARE Medical Systems, Inc. designs, develops, and manufactures premium compact performance ultrasound solutions, which combine revolutionary technology with an innovative physical design. Zone Sonography technology, ZONARE's unique patented approach to ultrasound imaging, is focused on bringing the highest performance to all clinical settings, leading to advanced diagnostic capabilities, more cost effective operation and increased value to providers. For more information, please visit our web site at www.zonare.com.
Source: ZONARE Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.